Leading Diabetes Organizations Issue Consensus Statement Defining Health Outcomes beyond HbA1c The Type 1 Diabetes Outcomes Program, organized by JDRF, has identified and defined clinically meaningful T1D outcomes other than the standard measure of HbA1c. A committee representing leading U.S. diabetes clinical and research organizations has issued a consensus statement that identifies and defines [...]

As a partner in the Diabetes Emergency Relief Coalition, T1D Exchange and its partners seek to provide support for those affected by Hurricane Harvey and Hurricane Irma. As part of our efforts, we have been reaching out to participants in our online patient/caregiver community in Glu (myglu.org) to inform them of ways they can [...]

Proven leader will oversee research program designed to incorporate patient-reported experiences to impact research, clinical care, and outcomes BOSTON, MA, August 15, 2017 – Alicia H. McAuliffe-Fogarty, PhD, CPsychol has been named vice president of patient-centered research for T1D Exchange, a Boston-based nonprofit organization uniting those affected by disease with those dedicated to accelerating [...]

Effort Aims to Accelerate Development of the Admetsys Automated Insulin Delivery System for Hospitals and Surgical Centers BOSTON, MA, June 6, 2017 – T1D Exchange, an organization dedicated to accelerating therapies and improving care in type 1 diabetes, today announced the organization has invested in Admetsys, the first company to develop an artificial pancreas [...]

BOSTON, MA, April 11, 2016 – T1D Exchange, an organization dedicated to accelerating therapies and improving care in type 1 diabetes, today announced the election of a new Board member and the addition of three executives to its leadership team. These additions demonstrate the organization’s rapid growth as it continues to build strategic initiatives [...]

T1D Exchange recently published the results of a major study that confirms the use of Continuous Glucose Monitoring (CGM) without regular use of confirmatory Blood Glucose Measurements (BGM) is as safe and effective as use of CGM with confirmatory BGM. This multi-center study enrolled 226 adults with type 1 diabetes (T1D). All study participants were [...]

T1D Exchange is pleased to partner with 72 organizations that advocate on behalf of people with chronic, serious, and life-threatening diseases such as type 1 diabetes (T1D) to educate the incoming administration and Congress on the unique health insurance needs of our community. On December 14, 2016, we sent a letter to President-elect Trump and [...]

Integrated Medical and Enable Biosciences selected as the co-winners of the first open, global competition to accelerate products and solutions to improve the lives of those living with type 1 and type 2 diabetes Boston, MA – October 21, 2016 – T1D Exchange, an organization dedicated to accelerating research and improving outcomes in type 1 diabetes, [...]

Finalists to present innovative advancements in diabetes diagnostics, therapeutics, devices, or solutions that aim to improve patient outcomes for those living with type 1 and type 2 diabetes Boston, MA – October 13, 2016 – T1D Exchange, an organization dedicated to accelerating research and improving outcomes in type 1 diabetes, and M2D2, a joint venture [...]

About

T1D Exchange pushes the boundary of the traditional research and development model by connecting the experience of living with T1D to the data about the disease. The result is a place where different perspectives are exchanged and faster progress can be made.